Eli Lilly, Elanco and Trifexis
Trifexis is made by Elanco, a global, innovation-driven company that develops and markets products to improve animal health production in more than 75 countries. Established in 1954 as a division of Eli Lilly and Company, Elanco Animal Health enables veterinarians to help pets live longer, healthier, higher quality lives.
Elanco develops and delivers safe products for consumers, animals and the environment. All of our products conform to rigorous regulatory oversight and quality assurance systems that are built on consistency, dependability, accountability and traceability.
GET MORE INFO AT ELANCO.US
IMPORTANT SAFETY INFORMATION
The use of ivermectin at higher than FDA-approved doses at the same time as Trifexis can result in serious side effects. Treatment with fewer than three monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Trifexis, dogs should be tested for existing heartworm infection. Use with caution in breeding females. The safe use of Trifexis in breeding males has not been evaluated. Use with caution in dogs with pre-existing epilepsy.
The most common adverse reactions reported are vomiting, depression/lethargy, itching, decreased appetite, and diarrhea. To ensure heartworm prevention, observe your dog for one hour after administration. If vomiting occurs within an hour of administration, redose with another full dose. Puppies less than 14 weeks of age may experience a higher rate of vomiting. Like all medications, keep Trifexis out of reach of children.
View full product label for complete safety information.